Free Trial

Semler Scientific, Inc. (NASDAQ:SMLR) Shares Sold by Dimensional Fund Advisors LP

Semler Scientific logo with Medical background

Dimensional Fund Advisors LP trimmed its holdings in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 18.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 150,327 shares of the company's stock after selling 34,955 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.62% of Semler Scientific worth $8,119,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Capital International Investors acquired a new position in Semler Scientific in the fourth quarter valued at $30,813,000. Shariaportfolio Inc. increased its position in Semler Scientific by 4.5% in the 4th quarter. Shariaportfolio Inc. now owns 160,453 shares of the company's stock valued at $8,664,000 after acquiring an additional 6,837 shares during the period. Geode Capital Management LLC increased its position in Semler Scientific by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 140,423 shares of the company's stock valued at $7,584,000 after acquiring an additional 4,464 shares during the period. Thames Capital Management LLC purchased a new stake in Semler Scientific during the 4th quarter valued at approximately $6,465,000. Finally, Principal Financial Group Inc. lifted its position in Semler Scientific by 633.1% during the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock worth $6,074,000 after acquiring an additional 97,144 shares during the period. Hedge funds and other institutional investors own 49.37% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital upped their price target on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research note on Friday, January 24th.

Check Out Our Latest Analysis on Semler Scientific

Semler Scientific Stock Performance

Shares of Semler Scientific stock opened at $34.79 on Friday. The company has a market cap of $333.88 million, a P/E ratio of 7.09 and a beta of 1.33. The firm has a fifty day moving average of $35.05 and a two-hundred day moving average of $46.60. Semler Scientific, Inc. has a one year low of $21.77 and a one year high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts' consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $12.41 million during the quarter.

Semler Scientific Company Profile

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Stories

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLR - Free Report).

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Semler Scientific Right Now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines